MicroRNAs as biomarkers and therapeutic targets in cancer Alejandro Moro
Texto completo
Documento similar
In the “big picture” perspective of the recent years that we have described in Brazil, Spain, Portugal and Puerto Rico there are some similarities and important differences,
Of special concern for this work are outbreaks formed by the benthic dinoflagellate Ostreopsis (Schmidt), including several species producers of palytoxin (PLTX)-like compounds,
[r]
Scarcity: The resources available Albani, are not very difficult to achieve, since with regard to human resources, with a good selection and training of its employees
In this work, we have undertaken the study of SUZ12, a Polycomb group protein and the microRNAs (miRNA) expressed by the oncogenic Epstein Barr Virus (EBV) in
Figure 4. Overview of the mutations identified in PRORADIUM cohort. A) Bar graph representing the frequency of mutational status described as a benign, pathogenic
Previous work has shown that VEGF up-regulates endothelial Adamts1 expression in a Protein Kinase C (PKC)-dependent manner and has involved the CN-NFAT pathway in Adamts1 gene
Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLC. Curr Pharm Des. [42] Velasco-Velazquez MA, Popov VM, Lisanti MP, Pestell RG. The role of breast cancer